Suggestions

Du même auteur

Chemotherapy Treatment Doesn't Beneficiate to a Group of Elderly AML Patients with Absence of Complex Karyotype and Circulating Blasts

Archive ouverte | Gruson, Berengere | CCSD

60th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA, DEC 01-04, 2018. International audience. IntroductionAlthough the median age at diagnosis of acute myeloid leukemia (AML) is 67 years, ...

Oncogenic Predictors of Outcome in Older AML Patients Treated Intensively. Analysis of the ALFA-1200 Trial

Archive ouverte | Itzykson, Raphael | CCSD

60th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA, DEC 01-04, 2018. International audience

Clinical significance of abcb1 in acute myeloid leukemia: a comprehensive study

Archive ouverte | Boyer, Thomas | CCSD

International audience. ABCB1 is a member of the ATP binding cassette transporter family and high ABCB1 activity is considered as a poor prognostic factor in acute myeloid leukemia (AML) treated with intensive chemo...

Chargement des enrichissements...